Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose-Response Relationship, Drug”

99 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 99 results

Not applicableEnded earlyNCT00338091
What this trial is testing

Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency

Who this might be right for
Renal Insufficiency,ChronicDisease ProgressionProteinuria+3 more
Southern Medical University, China
Not applicableStudy completedNCT00015652
What this trial is testing

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT03568396
What this trial is testing

Validation of Pupillary Response to Nociceptive Stimulation in Cardiac Surgery During Extracorporeal Circulation Period

Who this might be right for
PupilAnalgesicsOpioid Use+9 more
University Hospital, Tours 30
Early research (Phase 1)Study completedNCT00002427
What this trial is testing

Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults

Who this might be right for
HIV Infections
Research Institute for Genetic and Human Therapy 225
Not applicableStudy completedNCT03240055
What this trial is testing

The Effects of Spinal Anesthesia on ED50 and BIS50 of Etomidate for the Loss of Consciousness

Who this might be right for
Dose-Response Relationship, Drug
General Hospital of Ningxia Medical University 54
Large-scale testing (Phase 3)Study completedNCT00000949
What this trial is testing

Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 460
Early research (Phase 1)UnknownNCT00002449
What this trial is testing

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

Who this might be right for
HIV Infections
Chiron Corporation 212
Testing effectiveness (Phase 2)Study completedNCT00000909
What this trial is testing

Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Large-scale testing (Phase 3)Looking for participantsNCT06740214
What this trial is testing

Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty

Who this might be right for
Pain, PostoperativeAnalgesic EffectTotal Knee Arthroplasty+2 more
The University of Hong Kong 177
Early research (Phase 1)Study completedNCT00000729
What this trial is testing

Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT00002239
What this trial is testing

Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Who this might be right for
HIV Infections
Hoffmann-La Roche 68
Not applicableEnded earlyNCT03320564
What this trial is testing

Infiltration Effect on SUV

Who this might be right for
Dose Response Relationship, Drug
Wake Forest University Health Sciences 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05361668
What this trial is testing

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Who this might be right for
Carcinoid SyndromeCarcinoidCarcinoid Tumor+6 more
Crinetics Pharmaceuticals Inc. 36
Early research (Phase 1)Study completedNCT00001010
What this trial is testing

Zidovudine Plus Acyclovir in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT00006075
What this trial is testing

Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 150
Post-approval studies (Phase 4)Study completedNCT00776425
What this trial is testing

The Quality of Life and Treatment Response to Once Weekly Epoetin Beta (Recormon) Treatment in Anemic Participants With Solid and Lymphoid Malignancies

Who this might be right for
Anemia
Hoffmann-La Roche 117
Early research (Phase 1)Study completedNCT00000725
What this trial is testing

A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableStudy completedNCT00302913
What this trial is testing

Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition

Who this might be right for
Coronary Artery DiseaseDrug Resistance
University Heart Center Freiburg - Bad Krozingen 120
Not applicableLooking for participantsNCT07183579
What this trial is testing

Effective Dosing of Burosumab in XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
University of Nottingham 120
Not applicableStudy completedNCT00002023
What this trial is testing

An Oral Dose-Ranging Finding Study in Patients With HIV Disease, CDC Classification Groups IIB, III, and IV-C2

Who this might be right for
HIV Infections
Glaxo Wellcome
Load More Results